Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPOMAL: Erythropoietin for Cerebral Malaria in Children
NCT00697164Phase 3Unknown
- Sponsor
- Claude Bernard Lyon 1 University
- Start
- Oct 2007
- Primary completion
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of erythropoietin in cerebral malaria (CM), sponsored by Claude Bernard Lyon 1 University. Status: unknown.
02
Drugs
erythropoietin
03
Conditions
cerebral malaria (CM)
Beyond the preview
Go deeper on NCT00697164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697164.